Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 14, 2017 13:34 ET | Source: Nobilis Therapeutics, Inc.

Nobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic Disorder

PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...